BTIG Initiates Coverage On Definitive Healthcare with Buy Rating, Announces Price Target of $7
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst David Larsen has initiated coverage on Definitive Healthcare (NASDAQ:DH) with a Buy rating and set a price target of $7.
September 17, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG has initiated coverage on Definitive Healthcare with a Buy rating and a price target of $7, indicating a positive outlook.
The initiation of coverage with a Buy rating and a specific price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100